Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CCR6 | P51684 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL692903 | 0.90 | PKM (0.37) | KDM4EALOX12CYP3A4TDP1MAPT | |
| SCHEMBL600770 | 0.84 | KDM4E (0.44) | KDM4EALOX12CYP3A4TDP1MAPT | |
| SCHEMBL15226760 | 0.79 | TSHR (0.36) | KDM4EALOX12CYP3A4TDP1HTR2A | |
| SCHEMBL3717116 | 0.77 | PKM (0.42) | KDM4EALOX12CYP3A4TDP1MAPT | |
| SCHEMBL600529 | 0.77 | KDM4E (0.47) | KDM4EALOX12CYP3A4TDP1MAPT | |
| SCHEMBL14969487 | 0.76 | KDM4E (0.50) | KDM4EALOX12CYP3A4TDP1MAPT | |
| SCHEMBL14969485 | 0.76 | KDM4E (0.50) | KDM4EALOX12CYP3A4TDP1MAPT | |
| SCHEMBL571782 | 0.76 | KDM4E (0.50) | KDM4EALOX12CYP3A4TDP1MAPT | |
| SCHEMBL9953942 | 0.76 | KDM4E (0.34) | KDM4EALOX12CYP3A4TDP1MAPT | |
| Water SCHEMBL6469700 | 0.75 | KDM4E (0.49) | KDM4EALOX12CYP3A4TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9414595-B2 | Use of anthranilic acid diamide derivatives for pest control in transgenic crops | BAYER CROPSCIENCE AG (DE) | 2016-08-16 | — | — | US | disclosed |
| US-20140329676-A1 | USE OF ANTHRANILIC ACID DIAMIDE DERIVATIVES FOR PEST CONTROL IN TRANSGENIC CROPS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2014-11-06 | — | — | US | disclosed |
| US-8586628-B2 | Use of Propineb as bird repellent | BAYER CROPSCIENCE AG (DE) | 2013-11-19 | — | — | US | disclosed |
| US-20110269832-A1 | USE OF PROPINEB AS BIRD REPELLENT | BAYER CROPSCIENCE AG (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20100273874-A1 | USE OF PROPINEB AS BIRD REPELLENT | BAYER CROPSCIENCE AG (DE) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140329676-A1 | USE OF ANTHRANILIC ACID DIAMIDE DERIVATIVES FOR PEST CONTROL IN TRANSGENIC CROPS | AADAC, DDT, QDPR | KDM4E 1189/4885ALOX12 3482/4885CYP3A4 1953/4885 |
| US-20110269832-A1 | USE OF PROPINEB AS BIRD REPELLENT | NMBR, EPHB4, EPHB1 | KDM4E 1792/4885ALOX12 4375/4885CYP3A4 1756/4885 |
| US-20100273874-A1 | USE OF PROPINEB AS BIRD REPELLENT | NMBR, EPHB4, EPHB1 | KDM4E 1792/4885ALOX12 4375/4885CYP3A4 1756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.